MedDataX Logo

Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System

NCT ID: NCT01877902

Last Updated: 2014-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

190 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carcinoma, Non-Small-Cell Lung

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pemetrexed 500 mg/m 2

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years
* Confirmed diagnosis of metastatic NSCLC
* Pemetrexed Starts 1st line (either induction or maintenance) in any of the following periods:
* January 1, 2010 to March 31, 2010
* October 1, 2011 to December 31, 2011

Exclusion Criteria

* Patients receiving pemetrexed within a clinical trial protocol because it is an experimental environment that does not reflect clinical practice.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundación Pública Andaluza Progreso y Salud

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Javier Bautista Paloma

Role: PRINCIPAL_INVESTIGATOR

Hospitales Universitarios Virgen del Rocío

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital La Línea

Algeciras, Cádiz, Spain

Site Status RECRUITING

Hospital Punta de Europa

Algeciras, Cádiz, Spain

Site Status RECRUITING

Hospital Jerez de la Frontera

Jerez de la Frontera, Cádiz, Spain

Site Status RECRUITING

Hospital Costa del Sol

Marbella, Cádiz, Spain

Site Status RECRUITING

Hospital de Puerto Real

Puerto Real, Cádiz, Spain

Site Status RECRUITING

Hospital de Baza

Baza, Granada, Spain

Site Status RECRUITING

Hospital Universitario Torrecardenas

Almería, , Spain

Site Status RECRUITING

Hospital Universitario Puerta del Mar

Cadiz, , Spain

Site Status RECRUITING

Hospital Universitario Reina Sofía

Córdoba, , Spain

Site Status RECRUITING

Hospital San Cecilio

Granada, , Spain

Site Status RECRUITING

Hospital Santa Ana

Granada, , Spain

Site Status RECRUITING

Hospital Universitario Virgen de las Nieves

Granada, , Spain

Site Status RECRUITING

Hospital Universitario Juan Ramón Jiménez

Huelva, , Spain

Site Status RECRUITING

Hospital Regional de Málaga

Málaga, , Spain

Site Status RECRUITING

Hospital Universitario Virgen de la Victoria

Málaga, , Spain

Site Status RECRUITING

Hospital Universitario Virgen de Valme

Seville, , Spain

Site Status RECRUITING

Hospital Universitario Virgen del Rocío

Seville, , Spain

Site Status RECRUITING

Hospital Universitario Virgen Macarena

Seville, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Javier Bautista Paloma

Role: CONTACT

Phone: 955 01 20 00

María del Mar Benjumea Vargas

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

José Carlos Roldán

Role: primary

Pablo Villanueva Jiménez

Role: primary

Rocío Gavira Moreno

Role: primary

Margarita Garrido

Role: primary

Carmen Martínez Díaz

Role: primary

Francisco Nieto Cobo

Role: primary

Juan José Fernández Avila

Role: primary

María José Martínez Bautista

Role: primary

Ana Isabel Gago Sánchez

Role: primary

Miguel Damas Fernández Fijares

Role: primary

Marcos Camacho Romera

Role: primary

Inmaculada Vallejo Rodríguez

Role: primary

Mª Teresa Garrido Martínez

Role: primary

Beatriz Mora Rodríguez

Role: primary

Begoña Muros de Fuentes

Role: primary

Silvia Artecho

Role: primary

Javier Bautista Paloma

Role: primary

Nuria Muñoz Muñoz

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FPS-PEM-2013-06

Identifier Type: -

Identifier Source: org_study_id